Major Program
NCI Community Oncology Research Program
Research Group
Community Oncology and Prevention Trials
Sponsor
Mayo Clinic
Status
Completed
ClinicalTrials.gov ID
For more information, see ClinicalTrials.gov NCT02063698
This randomized pilot clinical trial studies whether auranofin will relieve pain following paclitaxel in patients who have previously experienced paclitaxel-induced pain. Auranofin is a drug given by mouth to treat other diseases such as rheumatoid arthritis, and is being studied to see if it will decrease pain following paclitaxel.
Intervention
auranofin, placebo, questionnaire administration
Condition
Pain
Investigators
Aminah Jatoi